Cobroxin is the first over-the-counter pain reliever clinically proven to treat moderate to severe (Stage 2) pain.
NutraPharma quotes (NPHC.OB)
Patents - Paul F. Reid:
United States Patent Application 20070190167
Kind Code A1
Reid; Paul F. ; et al. August 16, 2007
Use of cobratoxin as an analgesic
A composition of matter for an analgesia and its method of use is disclosed. The method of use is for the treatment of chronic pain, especially to the treatment of heretofore intractable pain as associated with advanced cancer. The pain associated with neurological conditions, rheumatoid arthritis, viral infections and lesions is also contemplated. The method includes administering to a host an alpha-neurotoxin that is characterized by its ability to blocking of the action of acetylcholine at nicotinic acetylcholine receptors.
Inventors: Reid; Paul F.; (Plantation, FL) ; Qin; Zheng Hong; (Plantation, FL)
1. A method of treatment of pain in a host by administering a pharmaceutical composition of matter comprising a therapeutically effective amount of cobratoxin and a pharmaceutically acceptable carrier base for use in inhibiting or controlling pain.